(Date:5/12/2008)...-- NutraCea (OTC Bulletin Board:,NTRZ), a world le...rch and,technology, today announced financial resu...nsolidated net revenues rose 155% to $5.1 million ...dated net revenues of $2.0,million for the first q...arily due to a $860,000 increase in sales of produ...
(Date:5/12/2008)...niversity of Michigan Comprehensive Cancer Center ... patients are more likely to survive cancers of th...y, they found that cancers linked to HPV, or human...t chemotherapy and radiation treatments, while tum...actor receptor are the least responsive and most d...
(Date:5/12/2008)...e-FirstCall/ -- China Yingxia,International, Inc. ...e,Company"), a leading provider in the nutraceutic...e and distribution of organic nutritional food,pro...the People,s Republic,of China ("PRC"), announced ...ay 16, 2008, at 10:00 a.m. EDT, to discuss the Com...
(Date:5/12/2008)..., Montreal, May 12, 2008 A team of researchers ...enafil protects the heart in mice with Duchenne mu...ine Des Rosiers from the Universit de Montral and ...h Dr. Basil Petrof of the Research Institute of th...hristian Deschepper of the Institut de recherches ...
Breaking Medicine News(10 mins):Health News:NutraCea Announces First Quarter 2008 Financial Results 2Health News:NutraCea Announces First Quarter 2008 Financial Results 3Health News:NutraCea Announces First Quarter 2008 Financial Results 4Health News:NutraCea Announces First Quarter 2008 Financial Results 5Health News:NutraCea Announces First Quarter 2008 Financial Results 6Health News:HPV linked to better survival in tonsil, tongue cancer, U-M study finds 2Health News:HPV linked to better survival in tonsil, tongue cancer, U-M study finds 3Health News:China Yingxia International, Inc. Announces Conference Call to Discuss First Quarter 2008 Results 2Health News:New approach to protect the hearts of patients with muscular dystrophy 2Health News:New approach to protect the hearts of patients with muscular dystrophy 3...m of researchers have revealed the connection betw...ormation in patients //at a higher risk for stroke...e due to blockages containing calcium in the main ...ain by carotid artery. These blockages, or athero...
...stern Nigeria, has reported the deadly H5N1 strain... that in most //of the other parts of Africa, the ...African country to be hit by bird flu, has not rep...s warn that due to ineffective surveillance, cases...
...o begging in order to pay his wife's medical bills...nisa was admitted to the Tata Memorial Hospital in...ts said. After treatment, she was declared fit on ...ked to receive a whopping Rs.22,000 bill - an amou...
...ors at the All India Institute of Medical Sciences...vention to ensure strict implementation of reserva...gory students and doctors at the institute. React...he institute, Medicos Forum for Equal Opportunitie...
Other Medicine News:(Date:5/12/2008)...1 Clinical Data of MDX-1100 at Digestive Disease W...TON, N.J., May 12 /- Medare...as initiated the Phase 2 clinical,development prog... that,targets CXCL10 (also known as IP-10), in ulc.... MDX-1100 could potentially treat UC and RA by,su...
(Date:5/12/2008)...12 /PRNewswire-USNewswire/ -- GlaxoSmithKline (GSK...Group (BIG), a leading,academic breast cancer rese...anish Breast Cancer Cooperative Group (SOLTI), tod... that will examine the role of TYKERB(R) in the,tr...vant Lapatinib and/or,Trastuzumab Treatment Optimi...
(Date:5/9/2008)...will play key role in national effort probing for,...Education Specialist, Pennsylvania Game Commissio...cle are available from the,Game Commission,s websi...Release,#049-08.", HARRISBURG, Pa., May 7 /PRNe...sion has found itself on a new frontier: it is wor...
(Date:5/9/2008).../PRNewswire-USNewswire/ -- Osteoarthritis is a,pai...ffects almost 50,million people in the United Stat...bone joints. The novel investigational pain medica..., provided significant relief,for patients with jo...lacebo, and with fewer gastrointestinal side effec...
Breaking Medicine Technology:Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis 2Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis 3Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis 4TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 2TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 3TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 4TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 5TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 6TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 7White Nose Syndrome: Is Pennsylvania Next? 2White Nose Syndrome: Is Pennsylvania Next? 3White Nose Syndrome: Is Pennsylvania Next? 4White Nose Syndrome: Is Pennsylvania Next? 5White Nose Syndrome: Is Pennsylvania Next? 6Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 2Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 3Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 4Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 5Johnson 26 Johnson to Participate in Morgan Stanley Conference 17765 1Analysis shows combining sorafenib with carboplatin paclitaxel adds no benefit in lung cancer 17762 1Analysis shows combining sorafenib with carboplatin paclitaxel adds no benefit in lung cancer 17762 2Finding God with biocomplexity 3057 1Finding God with biocomplexity 3057 2Finding God with biocomplexity 3057 3Different processes govern sight light detection 17756 1Different processes govern sight light detection 17756 2..., 2007 - Cobalis Corp.,(OTCBB:CLSC), a pharmaceuti...gy medications, today reported preliminary top-lin...ts drug,PreHistin(TM) in patients with moderate to...monly known as hay fever. The trials,showed very l...eated patient groups, thereby leaving no room to,d...
...2007-A virus that has been,specifically designed b...y to cancer is showing early promise in a prelimin...erence Lugano (ECLU),Switzerland. , The virus, ca...ified so that it selectively replicates in virus c...eplicate in normal, healthy cells, so our hope is,...
Other Medicine Technology:Cobalis Reports Phase III Trial Results for PreHistin in Seasonal,Allergic Rhinitis 2Cobalis Reports Phase III Trial Results for PreHistin in Seasonal,Allergic Rhinitis 3Cobalis Reports Phase III Trial Results for PreHistin in Seasonal,Allergic Rhinitis 4Cobalis Reports Phase III Trial Results for PreHistin in Seasonal,Allergic Rhinitis 5MediGene Announces Cancer-Fighting Virus Shows Promise in Early,Clinical Trial 2MediGene Announces Cancer-Fighting Virus Shows Promise in Early,Clinical Trial 3MediGene Announces Cancer-Fighting Virus Shows Promise in Early,Clinical Trial 4MediGene Announces Cancer-Fighting Virus Shows Promise in Early,Clinical Trial 5...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
Medicine Products: